Cargando…
A Novel Function for KLF4 in Modulating the De-Differentiation of EpCAM(−)/CD133(−) nonStem Cells into EpCAM(+)/CD133(+) Liver Cancer Stem Cells in HCC Cell Line HuH7
The complex and heterogeneous nature of hepatocellular carcinoma (HCC) hampers the identification of effective therapeutic strategies. Cancer stem cells (CSCs) represent a fraction of cells within tumors with the ability to self-renew and differentiate, and thus significantly contribute to the forma...
Autores principales: | Firtina Karagonlar, Zeynep, Akbari, Soheil, Karabicici, Mustafa, Sahin, Eren, Tercan Avci, Sanem, Ersoy, Nevin, Eren Ates, Kıvılcım, Balli, Tugsan, Karacicek, Bilge, Kaplan, Kubra Nur, Celiker, Canan, Atabey, Nese, Erdal, Esra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290717/ https://www.ncbi.nlm.nih.gov/pubmed/32408542 http://dx.doi.org/10.3390/cells9051198 |
Ejemplares similares
-
Doxorubicin‐induced senescence promotes stemness and tumorigenicity in EpCAM−/CD133− nonstem cell population in hepatocellular carcinoma cell line, HuH‐7
por: Karabicici, Mustafa, et al.
Publicado: (2021) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
CD133(+)EpCAM(+) Phenotype Possesses More Characteristics of Tumor Initiating Cells in Hepatocellular Carcinoma Huh7 Cells
por: Chen, Yi, et al.
Publicado: (2012) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014) -
Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)